Wells Fargo’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,391
| Closed | -$195 | – | 7161 |
|
|
2024
Q1 | $195 | Buy |
1,391
+80
| +6% | +$11 | ﹤0.01% | 6108 |
|
|
2023
Q4 | $190 | Sell |
1,311
-3,977
| -75% | -$576 | ﹤0.01% | 6178 |
|
|
2023
Q3 | $926 | Buy |
5,288
+3,038
| +135% | +$532 | ﹤0.01% | 5845 |
|
|
2023
Q2 | $7.02K | Buy |
2,250
+108
| +5% | +$337 | ﹤0.01% | 5692 |
|
|
2023
Q1 | $5.48K | Buy |
2,142
+2
| +0.1% | +$5 | ﹤0.01% | 5707 |
|
|
2022
Q4 | $3.19K | Buy |
2,140
+12
| +0.6% | +$18 | ﹤0.01% | 5570 |
|
|
2022
Q3 | $3K | Buy |
2,128
+65
| +3% | +$92 | ﹤0.01% | 5773 |
|
|
2022
Q2 | $3K | Buy |
2,063
+6
| +0.3% | +$9 | ﹤0.01% | 5952 |
|
|
2022
Q1 | $5K | Hold |
2,057
| – | – | ﹤0.01% | 6137 |
|
|
2021
Q4 | $9K | Sell |
2,057
-1,197
| -37% | -$5.24K | ﹤0.01% | 6057 |
|
|
2021
Q3 | $26K | Sell |
3,254
-3
| -0.1% | -$24 | ﹤0.01% | 5565 |
|
|
2021
Q2 | $32K | Sell |
3,257
-13,755
| -81% | -$135K | ﹤0.01% | 5414 |
|
|
2021
Q1 | $150K | Sell |
17,012
-17,599
| -51% | -$155K | ﹤0.01% | 4973 |
|
|
2020
Q4 | $354K | Buy |
34,611
+27,796
| +408% | +$284K | ﹤0.01% | 4671 |
|
|
2020
Q3 | $62K | Sell |
6,815
-9,403
| -58% | -$85.5K | ﹤0.01% | 5207 |
|
|
2020
Q2 | $116K | Buy |
16,218
+10,933
| +207% | +$78.2K | ﹤0.01% | 4955 |
|
|
2020
Q1 | $50K | Buy |
5,285
+5,148
| +3,758% | +$48.7K | ﹤0.01% | 5122 |
|
|
2019
Q4 | $2K | Buy |
+137
| New | +$2K | ﹤0.01% | 5777 |
|